000 01437 a2200385 4500
005 20250513110542.0
264 0 _c19970123
008 199701s 0 0 eng d
022 _a0360-3016
024 7 _a10.1016/s0360-3016(96)00432-4
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRussell, K J
245 0 0 _aPreferential radiosensitization of G1 checkpoint-deficient cells by methylxanthines.
_h[electronic resource]
260 _bInternational journal of radiation oncology, biology, physics
_cDec 1996
300 _a1099-106 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aCell Survival
_xradiation effects
650 0 4 _aG1 Phase
_xdrug effects
650 0 4 _aHumans
650 0 4 _aPentoxifylline
_xanalogs & derivatives
650 0 4 _aProto-Oncogene Proteins p21(ras)
_xanalysis
650 0 4 _aRadiation-Sensitizing Agents
_xpharmacology
650 0 4 _aTumor Cells, Cultured
650 0 4 _aTumor Suppressor Protein p53
_xanalysis
700 1 _aWiens, L W
700 1 _aDemers, G W
700 1 _aGalloway, D A
700 1 _aLe, T
700 1 _aRice, G C
700 1 _aBianco, J A
700 1 _aSinger, J W
700 1 _aGroudine, M
773 0 _tInternational journal of radiation oncology, biology, physics
_gvol. 36
_gno. 5
_gp. 1099-106
856 4 0 _uhttps://doi.org/10.1016/s0360-3016(96)00432-4
_zAvailable from publisher's website
999 _c8976490
_d8976490